Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | ANPEP | P15144 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11890301 | 0.84 | — | — | |
| SCHEMBL11890306 | 0.84 | — | — | |
| SCHEMBL107498 | 0.84 | — | — | |
| SCHEMBL5509376 | 0.77 | ALDH1A1 (0.39) | TSHRALDH1A1 | |
| SCHEMBL1789330 | 0.77 | ALDH1A1 (0.39) | TSHRALDH1A1 | |
| SCHEMBL5505711 | 0.77 | ALDH1A1 (0.39) | TSHRALDH1A1 | |
| SCHEMBL12079309 | 0.77 | ALDH1A1 (0.39) | TSHRALDH1A1 | |
| SCHEMBL599901 | 0.77 | TSHR (0.47) | TSHRALDH1A1MAPK1ANPEP | |
| SCHEMBL13482188 | 0.77 | TSHR (0.32) | TSHRALDH1A1MAPK1ANPEP | |
| SCHEMBL10456925 | 0.77 | TSHR (0.33) | TSHRALDH1A1MAPK1ANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1352047-A1 | GELS FOR THE TARGETED RELEASE OF ODORIFEROUS SUBSTANCES | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-10-15 | — | — | EP | claimed |
| EP-1294792-A1 | ORGANOLEPTICALLY ACTIVE ALCOHOLS BONDED TO BIODEGRADABLE POLYESTER | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-03-26 | — | — | EP | claimed |
| WO-2002055648-A1 | GELS FOR THE TARGETED RELEASE OF ODORIFEROUS SUBSTANCES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2002-07-18 | — | — | WO | claimed |
| US-6369248-B1 | HYDROXY ESTERS FOR PERFUMES | GIVAUDAN SA (CH) | 2002-04-09 | — | — | US | claimed |
| WO-2001094442-A1 | ORGANOLEPTICALLY ACTIVE ALCOHOLS BONDED TO BIODEGRADABLE POLYESTER | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-12-13 | — | — | WO | claimed |
| US-6262287-B1 | POLYSILOXANE OLIGOMERS | GIVAUDAN-ROURE (INTERNATIONAL) SA (CH) | 2001-07-17 | — | — | US | claimed |
| EP-0980863-A1 | Oxime carboxylic acid derivatives | Givaudan Roure (International) S.A. (CH) | 2000-02-23 | — | — | EP | claimed |
| EP-0953562-A1 | Beta, gamma-unsaturated delta-keto esters | Givaudan Roure (International) S.A. (CH) | 1999-11-03 | — | — | EP | claimed |
| EP-0000771-A2 | 2,5,7-Trimethyloctane-3-ol and 2,4-dimethylnonane-8-ol; processes for their preparation; their use as olfactory agents; olfactory compositions containing them, as well as the preparation of such olfactory compositions | L. Givaudan & Cie Société Anonyme (CH) | 1979-02-21 | — | — | EP | claimed |
| EP-3279300-B1 | FRAGRANCE COMPOSITION | KAO CORP (JP) | 2019-03-27 | — | — | EP | disclosed |
| US-20180265805-A1 | RELEASE OF ODORIFEROUS SUBSTANCES FROM MICROCAPSULES | HENKEL AG & CO. KGAA (DE) | 2018-09-20 | — | — | US | disclosed |
| US-9981937-B2 | Orthoformic acid esters as pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2018-05-29 | — | — | US | disclosed |
| EP-3279300-A1 | FRAGRANCE COMPOSITION | KAO CORPORATION (JP) | 2018-02-07 | — | — | EP | disclosed |
| US-20170349565-A1 | ORTHOFORMIC ACID ESTERS AS PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2017-12-07 | — | — | US | disclosed |
| EP-0000771-B1 | 2,5,7-TRIMETHYLOCTANE-3-OL AND 2,4-DIMETHYLNONANE-8-OL; PROCESSES FOR THEIR PREPARATION; THEIR USE AS OLFACTORY AGENTS; OLFACTORY COMPOSITIONS CONTAINING THEM, AS WELL AS THE PREPARATION OF SUCH OLFACTORY COMPOSITIONS | L. Givaudan & Cie Société Anonyme (CH) | 1981-09-16 | — | — | EP | disclosed |
| EP-0000771-B1 | 2,5,7-TRIMETHYLOCTANE-3-OL AND 2,4-DIMETHYLNONANE-8-OL; PROCESSES FOR THEIR PREPARATION; THEIR USE AS OLFACTORY AGENTS; OLFACTORY COMPOSITIONS CONTAINING THEM, AS WELL AS THE PREPARATION OF SUCH OLFACTORY COMPOSITIONS | L. Givaudan & Cie Société Anonyme (CH) | 1981-09-16 | — | — | EP | disclosed |
| US-4198532-A | 2,5,7-TIRMETHYL-OCTAN-3-OL OR 6,8-DIMETHYL-NONAN-2-OL | GIVAUDAN CORPORATION (US) | 1980-04-15 | — | — | US | disclosed |
| EP-0000771-A2 | 2,5,7-Trimethyloctane-3-ol and 2,4-dimethylnonane-8-ol; processes for their preparation; their use as olfactory agents; olfactory compositions containing them, as well as the preparation of such olfactory compositions | L. Givaudan & Cie Société Anonyme (CH) | 1979-02-21 | — | — | EP | disclosed |
| EP-0000771-A2 | 2,5,7-Trimethyloctane-3-ol and 2,4-dimethylnonane-8-ol; processes for their preparation; their use as olfactory agents; olfactory compositions containing them, as well as the preparation of such olfactory compositions | L. Givaudan & Cie Société Anonyme (CH) | 1979-02-21 | — | — | EP | disclosed |
| EP-0000771-A2 | 2,5,7-Trimethyloctane-3-ol and 2,4-dimethylnonane-8-ol; processes for their preparation; their use as olfactory agents; olfactory compositions containing them, as well as the preparation of such olfactory compositions | L. Givaudan & Cie Société Anonyme (CH) | 1979-02-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170349565-A1 | ORTHOFORMIC ACID ESTERS AS PRO-FRAGRANCES | FAAH, NISCH, ELOVL6 | TSHR 3901/4885ALDH1A1 95/4885MAPK1 1840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.